NHF’s QMS is ISO – 9001:2015 Certified · Government of Jamaica

An agency of the Ministry of Health & Wellness

FOUR NEW DRUGS & MORE GENERIC LABELS ADDED TO NHF DRUG LIST IN NOVEMBER

FOUR NEW DRUGS & MORE GENERIC LABELS ADDED TO NHF DRUG LIST IN NOVEMBER

Four new active pharmaceutical ingredients – Infliximab, Sitagliptin, Nebivolol and Ketanserin, which were approved by the Medical Review Committee of the National Health Fund (NHF), have been added to the NHFCard Drug List. This brings the total number of active ingredients on the NHFcard Drug List to 199.

The Active Pharmaceutical Ingredient Infliximab is used to treat patients with rheumatoid arthritis. The NHFcard subsidy for each 100milligram vial of this injection on the Remicade label is $31,929.75.

Sitaglipin is used to treat diabetes and the tablets are available in strengths of 25 Milligrams, 50milligrams and 100milligrams. The NHFCard subsidy for these tablets on the Januvia Label is $23.60 for each 25 milligram.

Ketanserin, which is listed under vascular disease and diabetes, is used to treat skin ulcers due to complications of these diseases. The drug is available in the form of a gel with a NHFCard subsidy of $2,026.26 for the 78 gram tube, now available on the Sufrexal label.

Nebivolol is used to treat hypertension and Ischaemic Heart Disease. The NHFCard subsidy for the 2.5milligram tablet is $15.85 and for the 5 milligram tablet – $31.70 .

Three new generic labels which have been added are: Losartan H2K (Losartan Potassium) tablets which is listed under hypertension and diabetes, with a subsidy of $24.76 for each 50 milligram; Diclo-K (Diclofenac Potassium) 50 milligram tablets used for the treatment of arthritis with a subsidy of $6.05 each; Lefra (Leflunomide) 20 milligram tablets used for treating rheumatoid arthritis, with a subsidy of $200.93 each.

In keeping with its emphasis on encouraging monitoring of blood sugars for diabetics, the NHF has added TrueTrack Smart Glucometer and blood glucose test strips to the NHF Glucometer Programme, with the strips having a subsidy of $1,693.01 for the 50 strips pack size and Gluco Check V Visual Reagent Strips with a subsidy of $620.88 for the pack of 50. Also, a new label TC URS was added to the list of urine test strips, with a subsidy of $998.40 for the TC URS-2P Urine Reagent strips pack of 100 and a subsidy of $1,307 for the TC URS-10 Urine Reagent strips – pack of 100.

The NHF’s Medical Review Committee regularly reviews the items on the Individual Benefits Drug List, as well as new active ingredients and new labels, in order to make relevant changes to these lists and ensure the widest and best selection of both generic and brand name drugs for treating the conditions covered by the NHF.

An agency of the Ministry of Health & Wellness
NHF’s QMS is ISO – 9001:2015 Certified

National Health Fund The Towers,
6th Floor 25 Dominica Drive,
Kingston 5

(876) 906-1106 / (876) 906-4381

1-888-DIAL-NHF (342-5643)

[email protected]

National Health Fund © 2024. All Rights Reserved.